Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response-based Treatment for Children With Unresectable Localized Soft Tissue Sarcomas

NCT02784015 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02784015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02784015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response-based Treatment for Children With Unresectable Localized Soft Tissue Sarcomas
Lead sponsor
Samsung Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2016
Completion date
May 31, 2023
Enrollment
41 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable localized soft tissue sarcoma